Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05956236

Hip Prospective Study

Hip Prospective Study: Long-term Post-market Clinical Follow-up on the Use of SERF Hip Prostheses

Status
Recruiting
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Societe dEtude, de Recherche et de Fabrication · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In an evaluation report dated 2014, the HAS (Haute Autorité de Santé -French National Authority for Health) highlights that long-term clinical data on hip prostheses are needed in the context of the French healthcare system. In addition, per the European Regulation 2017/745, medical devices manufacturers shall conduct Post-Market Clinical Follow-up (PMCF) on their devices or provide a justification why PMCF is not applicable. Therefore, as part of the PMCF process of their hip prostheses, SERF wants to conduct a PMCF investigation to ensure the long-term real-life performance, safety and benefits of these prostheses. HiPS is a non-comparative, prospective, multicentric, national, 15-year follow-up clinical investigation.

Conditions

Timeline

Start date
2023-04-24
Primary completion
2046-04-01
Completion
2046-04-01
First posted
2023-07-21
Last updated
2026-04-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05956236. Inclusion in this directory is not an endorsement.

Hip Prospective Study (NCT05956236) · Clinical Trials Directory